The Effect of Grinberg Method (GM) Intervention on Low-back Pain (LBP) and Improving the Quality of Life
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01474447|
Recruitment Status : Unknown
Verified February 2013 by Tel-Aviv Sourasky Medical Center.
Recruitment status was: Recruiting
First Posted : November 18, 2011
Last Update Posted : March 1, 2013
The purpose of the research is to check the efficiency of practicing the tools of the Grinberg method (GM) in reducing Low-back Pain (LBP), reducing limitations in movement as a result of the pain, and improving the general quality of life.
The hypothesis suggests that by learning to perceive pain differently, the level of pain will reduce and general well-being improved.
|Condition or disease||Intervention/treatment||Phase|
|Low Back Pain (LBP)||Behavioral: Grinberg Method||Not Applicable|
The research will include 140 patients, who attended the pain clinic due to chronic LBP. Any change in the pharmacological regimen will be done with consult of the tending doctor and the change will be reported.
Tools and Methods A patient, whom volunteers to take part in the research, will be invited to the Ichilov Pain clinic in order to fill-in questionnaires and sign an informed consent form.
Each participant in the experiment group will participate in a series of 6 sessions lasting 1 hour each, extending between 6 to 8 consecutive weeks, with one of the qualified GM practitioners partaking in the experiment. Each participant will have all their sessions with the same GM practitioner throughout the experiment. Immediately after the last session, the participants will fill-in the same questionnaires given at the beginning of the experiment. The non-GM intervention group will answer the questionnaires after 6-8 weeks of pharmacological treatment only.
- General Details and Pain Questionnaire
- SF-MPQ Short Form McGill Pain Questionnaire, Ronald Melzack
- RMDQ - Roland Morris Disability Questionnaire
- SF 36 - The Short Form Health Survey
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||140 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||The Research Protocol: The Effect of Grinberg Method (GM) Intervention on Low-back Pain (LBP) and Improving the Quality of Life|
|Study Start Date :||December 2011|
|Estimated Primary Completion Date :||December 2013|
|Estimated Study Completion Date :||December 2013|
|Experimental: Grinberg Method||
Behavioral: Grinberg Method
The GM is a methodology of attention that teaches through expanding and focusing body attention to create a change and an improvement in pain and in quality of life. The method focuses on the way in which we experience pain, and offers an approach that trains people to use their attention and will in order to turn an unwanted experience that causes suffering, into a controlled experience in which they can take responsibility on the way they react to an existing pain. The method uses attention in order to learn the fixed ways in which we respond to pain in our body: where we focus our attention, what is the level of tension in our muscles, how we breathe and relax and more. It gives simple and effective tools to control all these, in order to create optimal conditions in the body to utilize its natural potential to recover and recuperate
- pain questionnaires that will assess the improvement on back pain in patients treated with the Grinberg method [ Time Frame: change of pain from baseline and after 8 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01474447
|Contact: Silviu Brill, M.Demail@example.com|
|Pain Medicine Unit||Recruiting|
|Tel Aviv, Israel|
|Contact: silviu Brill, M.D 972-3-6974477 firstname.lastname@example.org|
|Principal Investigator:||Silviu Brill, MD||Tel-Aviv Sourasky Medical Center|